Insulin transdermal (Phosphagenics)

透皮胰岛素

Report date: 2023/02/22 20:00:32

Base Information

Drug NameInsulin transdermal (Phosphagenics)
Drug Alias NameTPM/InsulinTPM-02
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTYRO3 protein tyrosine kinase stimulantsOrnithine decarboxylase stimulants
TargetsTYRO3 protein tyrosine kinaseOrnithine decarboxylase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Primary Ovarian Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhosphagenics
China Registration ClassN/A

Develop Information

Inactive CompaniesPhosphagenics
Active IndicationsPrimary Ovarian Insufficiency
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5
Related LinksWikipedia